Various scenarios within medical diagnostics are among the AI use cases that an official European watchdog has flagged as a potential source of hazards to fundamental human rights.

Drawing on nothing more than Facebook activity, psychiatric AI can distinguish individuals headed for hospitalization with schizophrenia from those with worsening mood disorders such as clinical depression and bipolar states. 

A women’s health technology company has received the FDA’s blessing to market deep learning-based software designed to help breast radiologists spot hard-to-find nascent cancers in 3D mammograms.

Researchers have demonstrated a machine learning model that can rule out COVID-19 in many emergency patients—and all the algorithm needs is data from routine ER blood tests.

The healthcare AI startup founded by developers of the Apple Watch has been greenlit to market an AI-powered mobile application that lets radiologists interpret images and share the results with patients in real time.

Parkinson’s disease is diagnosable early with a basic eye exam and AI, according to researchers at the University of Florida.

The COVID crisis has given AI a chance to shine for medical researchers this year—and shine it has, judging by one prominent center’s experience.

When it comes to predicting an individual’s risk of suffering a heart attack or stroke over the next 10 years, machine learning models are no more consistent than traditional statistical techniques.

The novel coronavirus has shown a nasty penchant for targeting the kidneys, and physicians can’t always tell which patients will need dialysis until they do. By then it’s often too late to save a life.

The FDA has greenlit a European company’s AI software package designed to streamline workflow for radiologists reading prostate MRIs.

Low-back imaging and interventions are often named among healthcare’s iffiest expenses due to the hit-or-miss predictability of the outcomes.

Knowing that antibodies as well as viruses bind to certain proteins in certain ways, scientists have come up with a technique to watch both sickness-signaling materials stick to microscopic beads prepared for the purpose.

Around the web

Two different companies announced that they are recalling all lots of the medication. 

CardioSmart, an online resource for both patients and clinicians, has a new editor. 

The funding includes $8.5 billion in American Rescue Plan resources for providers who treat Medicaid, Children's Health Insurance Program and Medicare patients.

Trimed Popup
Trimed Popup